Success Metrics

Clinical Success Rate

40.0%

Based on 2 completed trials

Completion Rate

40%(2/5)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Terminated

3(60%)

Phase Distribution

Ph not_applicable

80%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(3)

Detailed Status

Terminated3

Completed2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

40.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (20.0%)

N/A4 (80.0%)

Trials by Status

terminated360%

completed240%

Recent Activity

0 active trials

Showing 5 of 5

terminatednot_applicable

Dual Site-dual Channel Non-invasive Brain Stimulation for Language and Cognitive Function in Stroke Patients

NCT03486782

terminatednot_applicable

Transcranial Direct Current Stimulation for Post-Stroke Aphasia

NCT02461355

Clinical Trials (5)

Showing 5 of 5 trials

NCT03297450Not Applicable

TDCS and Aphasia Therapy in the Acute Phase After Stroke

Terminated

NCT03305614Phase 2

TDCS and Aphasia Therapy in the Chronic Phase After Stroke

Terminated

NCT03622411Not Applicable

Tablet-based Aphasia Therapy in the Chronic Phase

Completed

NCT03486782Not Applicable

Dual Site-dual Channel Non-invasive Brain Stimulation for Language and Cognitive Function in Stroke Patients

Completed

NCT02461355Not Applicable

Transcranial Direct Current Stimulation for Post-Stroke Aphasia

Terminated

All 5 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 5